Angle PLC represents values such as integrity, innovation, and excellence. As a company, Angle PLC is committed to delivering exceptional services and products to its clients. With a strong focus on customer satisfaction, Angle PLC aims to provide cutting-edge solutions and maintain a high level of reliability. The company's corporate philosophy revolves around fostering strong partnerships, driving technological advancements, and ensuring business sustainability. Angle PLC strives to be at the forefront of the industry, constantly seeking new opportunities and embracing challenges. By consistently demonstrating these values and embracing its corporate philosophy, Angle PLC has established itself as a trusted and respected company in the market.

Angle PLC is primarily present in the United Kingdom.

Angle PLC has achieved several significant milestones. The company successfully developed and commercialized Parsortix, its flagship product. Angle PLC received CE Mark certification for Parsortix, enabling its sale in Europe for clinical use. The company also secured FDA clearance for Parsortix for research use in the United States. Furthermore, Angle PLC has established collaborations with renowned research institutions and has successfully completed numerous clinical studies with positive results. These milestones demonstrate Angle PLC's commitment to advancing liquid biopsy technology for cancer diagnosis and monitoring.

Angle PLC, a pioneering medical technology company, was founded in 1980. Originally known as Medical Solutions PLC, Angle PLC changed its name in 2014 to reflect its focus on the innovative Parsortix system. The Parsortix system is a non-invasive diagnostic solution that enables the capture and analysis of rare circulating tumor cells from a simple blood test. Angle PLC has since become a global leader in liquid biopsy technologies and is dedicated to revolutionizing cancer diagnosis and treatment. With a strong track record of innovation and a relentless commitment to improving patient outcomes, Angle PLC continues to make significant contributions to the field of precision medicine.

The main competitors of Angle PLC in the market are Company A, Company B, and Company C.

Angle PLC is primarily active in the life sciences and healthcare industries.

The business model of Angle PLC revolves around providing innovative and advanced solutions for the life sciences and pharmaceutical industry. Angle specializes in developing and commercializing technologies that enable the capture and analysis of rare cells circulating in the bloodstream. By utilizing its patented Parsortix system, the company aims to aid in various applications including cancer diagnostics, personalized medicine, and drug development. By focusing on delivering accurate and reliable data, Angle PLC plays a crucial role in supporting and transforming the healthcare sector.

Poměr Angle P/E je 0.

Koeficient Angle tržních hodnot je 2,60.

AlleAktien kvalitní skóre pro Angle je 7/10.

očekávané Angle obrat je 14,82 mil. GBP.

Zisk pro Angle nelze v současnosti vypočítat.

Angle PLC is a company that performs routine chemical analysis and offers high-quality products and services for the life science industry. Its business model is based on three pillars: analytics, sample preparation, and consumables.

Angle vyplácí dividendu ve výši 0 GBP rozdělenou do výplat během roku.

Dividenda pro Angle momentálně nemůže být vypočítána nebo společnost žádnou dividendu nevyplácí.

ISIN společnosti Angle je GB0034330679.

WKN společnosti Angle je A0B7QK.

Ticker společnosti Angle je AGL.L.

Během posledních 12 měsíců vyplatila společnost Angle dividendu ve výši . To odpovídá dividendovému výnosu přibližně . Pro nadcházejících 12 měsíců se očekává, že Angle vyplatí dividendu ve výši 0 GBP.

Výnos z dividend společnosti Angle aktuálně činí .

Angle vyplácí čtvrtletní dividendu. Ta je distribuována v měsících .

Angle vyplácela v posledních 0 letech každý rok dividendu.

Očekává se, že v následujících 12 měsících budou dividendy ve výši 0 GBP. To odpovídá dividendovému výnosu 0 %.

Angle je přiřazen k sektoru 'Zdraví'.

Aby ses mohl podílet na poslední dividendě Angle ve výši 0 GBP, zaznamenané 7. 7. 2024, měl jsi mít akcii ve svém portfoliu před ex-dnem 7. 7. 2024.

Poslední dividendy byly vyplaceny dne 7. 7. 2024.

V roce 2023 společností Angle bylo vyplaceno 0 GBP ve formě dividend.

Dividendy společnosti Angle jsou vypláceny v GBP.